In common with certain other lymphoid neoplasms, cells of the human lymphocytic leukemia lines 1873 and 1929 are asparagine (ASN) auxotrophs. Asparagine synthetase (ASY), which is a housekeeping gene, is repressed and the promoting region of the gene is highly methylated. We now demonstrate in these cells multiple levels in control of the expression of this gene, in a system of cocultivation with macrophages and other cell types. In this system, mediated by cell-to-cell contact, ASY becomes expressed by the leukemic cells and they become prototrophic. Demethylation of ASY occurs; it follows expression and is permanent over multiple cell generations, but the cells return to auxotrophy with rapid repression of ASY on removal from cell contact. With ASY expression, the associated histone H3 at lysine position 9 (H3K9) becomes acetylated and H3K4, methylated. In contrast to other systems, H3K9 methylation does not characterize the repressed state. The changes leading from repression to induction of ASY and demethylation parallel the physiological changes specific to functional maturation of normal lymphoid precursors. The lability of expression of ASY has potential significance in determining the sensitivity of leukemic cells to L-asparaginase.
Introduction
L-asparaginase has become an established component of protocols for the treatment of ALL. 1, 2 Early findings on the inhibitory action of the enzyme on mouse lymphoma and certain other cells showed that they were asparagine (ASN) auxotrophs and had a low level of asparagine synthetase activity, in contrast to prototrophic variants. 3, 4 In auxotrophs, the asparagine synthetase gene (ASY) has been shown to be silenced. 5 ASY has been cloned and sequenced from human and animal sources [6] [7] [8] [9] and control of its expression in prototrophic (hepatic) cells has been shown to reside in a control element located in a highly conserved region of the promoter, which is responsive to deprivation of amino acids, glucose, and to endoplasmic stress. 9 Since evidence from multiple sources has correlated repression of genes with methylation of their promoters, 10, 11 we examined the promoter region of ASY in mouse lymphomas and showed that it contained a CpG island which was heavily methylated in ASN auxotrophic lines in vivo and in vitro but not in prototrophic variants or other intrinsically protrotophic lines. 5 We subsequently found a similar correlation among cell lines of a number of human leukemias. In these and in other lymphoid cells, a specific methyl-binding protein was identified whose binding motif overlapped the ASY response element so that transcription factor binding to oligomers containing this site was inhibited. 12 Further experiments, to be described in this paper, show that although methylation may have a role in inhibiting ASY in leukemic cells, and certainly expression is induced by 5-aza-2 0 deoxycytidine, 12 silencing occurs at multiple levels and methylation is not the sole, or necessarily the primary, component.
Gene expression (or silencing) is determined by chromatin structure, which governs accessibility of the gene to transcription factors and complexes (reviewed 13 ). The structure is modulated by covalent modifications in the amino terminal tails of histones (chiefly H3 and H4), 14 which form the nucleosomal cores and contact the gene. We examined patterns of modification, specifically of lysine in positions 4 and 9 of histone 3 (acetylation and methylation), which are known to have importance in expression and repression. 13, 15 We show that changes in modifications of these sites are linked in a distinctive way to the lability of ASY expression in leukemic cells.
Materials and methods

Leukemic cell lines and culture conditions
The cells used have been described earlier, 12, 16 the first, designated 1873 has B-cell and myleoid characteristics and t(4;11) (q21;q23), the other, 1929, expresses B-cell markers and has an anomalous t(9;22) (q34;q11). These cells grow in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and ASN, 50 mg/l. Slow proliferation is detected at 2.5 mg/l, but no proliferation occurs in its absence, and cells undergo apoptosis after 5 or more days.
Cocultivation experiments were performed usually using mouse peritoneal macrophages grown in DMEM and carried (five or more transfer generations) in T flasks. At approximately one-third confluence, leukemic cells were inoculated (1 Â 10 6 / ml). Similar cultures were prepared using 3T3, L cells and primary (second-third passage) cultures of embryo fibroblasts and amniocytes. Medium (with suspended cells) was replaced according to pH change. For long-term experiments, when the adherent layer became thick (at about 20-day intervals) portions were scraped off and, together with suspended cells, inoculated into fresh flasks. Conditioned medium was obtained from vigorously growing cocultures after phenol red had shown a distinct fall in pH. When suspended cells had been removed by centrifugation, the supernatant was mixed with an equal volume of fresh medium.
For proliferation assays (Celltiter 96 s , Promega, Madison, WI, USA), trypsinized suspensions of macrophages, or other supporting cells, were washed and suspended in DMEM (4 Â 10 5 /ml) before irradiation from a cobalt source (6000 rads). 3T3 and L cells were treated similarly. Human cells used to support leukemic cells were exposed to 3000 rads. Cells were dispensed (usually 50 ml containing 8 Â 10 3 cells/well) in 96-well plates and left for 6 h before adding leukemic cells (50 ml containing 4 Â 10 4 /well). For experiments with culture plate inserts, macrophages (not irradiated) were inoculated (4 Â 10 4 /ml) onto the surface of a Costar s Petri dish containing 20 ml of medium (D). After 3 h 1.5 Â 10 6 leukemic cells were added. The central well (porosity: 0.4 mm) was then inserted, which immediately filled with medium after which it was innoculated with an equal number of leukemic cells. Nine culture systems were set up, and at 48, 96, and 144 h, all suspended cells in the well and from the lower plate were separately removed for measurement of ASY expression.
DNA methylation analysis, and m-RNA expression analysis (real-time quantitative RT-PCR)
These were performed as previously described. 12 
Chromatin immunoprecipitation analysis (ChIP)
This was performed as previously described for amplification of the ASY promoting region. 12 The promoting region of p16 was amplified as described by Coombes et al, 17 using the primers 5 0 -GCGCTAGATTCCAATTC-3 0 and 5 0 -GCAGCATGGAGCCTTCG GCTGAC-3 0 . ChIP grade antibodies to histone H3 diacetyl K9 and H3 dimethyl K4 were obtained from Upstate Biotechnology, Lake Placid, NY, USA and to H3 dimethyl K9 from Abcam Inc., Cambridge, MA, USA.
Results
Growth properties of leukemic cells
Both 1873 and 1929 cell lines require ASN supplementation of culture medium for growth ( Figure 1) ; however, leukemic cells proliferated in ASN-depleted medium when grown in culture flasks together with mouse macrophages. We quantified this effect by proliferation assays in 96-well plates. Since measurable growth of the leukemic cells was partially masked by that of macrophages, we used irradiated macrophages that did not proliferate, and these provided a dose-dependent proliferative stimulus, which was detectable by 48 h at an innoculation ratio of leukemic cells to macrophages of 20:1 (Figure 1b) .
Various cell types were screened for growth promoting activity. Growth stimulation occurred not only with standard culture lines (L and 3T3) but with primary human fibroblasts and amniocyte cultures (Figure 1c and d) . Thus, although macrophages were particularly effective, within the range tested there was a lack of specificity as to cell type. By contrast, no proliferation occurred with plates coated with fibronectin or with the extracellular matrix product Matrigel. Macrophages 
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When cells that had been cocultured with macrophages for periods of 3-4 months with vigorous growth were suspended alone in DMEM or conditioned medium from proliferating cultures, they failed to divide, but resumed division in medium supplemented with ASN. A number of sublines were obtained from such cultures of both 1873 and 1929 cells, which, after several passages of suspended cells, were free of the supporting cells, as confirmed by regularly repeated microscopic observation of the flasks. These at all stages grew more slowly than the wild types, for example wild-type 1929 had a doubling time of 2271 h, three sublines had times of 3072, 3571, and 3671 h. In one exceptional subline (1873-SN3) initial growth was slow (doubling time 28 h), but after12 weeks it was observed to have an increased rate of acid production and its growth rate exceeded that of wild-type cells (21 vs 24 h). In all sublines, ASN dependence persisted permanently, over at least 150 generations.
Proliferation of leukemic cells in coculture was found, surprisingly, to be accompanied by the induction of ASY ( Figure 2 ) and indeed to levels comparable to those observed in intrinsically prototrophic cell lines, such as Jurkat and Raji. 12 This was not derived from the supporting cells. Not only were these firmly attached to the glass and therefore rare in the suspensions used, but the measurement of ASY expression by RT-PCR employed primers specific for human cDNA. However, when the leukemic cells were removed to fresh medium there was a dramatic fall in ASY expression, so that at 24 h it was no greater than in standard cultures not cocultivated. Induction of ASY and its subsequent repression, as described above, occurred similarly in ASN-supplemented medium.
In a further experiment, 1873 cells were placed in a culture system out of direct contact with macrophages. Leukemic cells were seeded together with mouse macrophages (unirradiated) on a Petri dish above which was placed a well (Costar s Plate) with a membrane of 0.4 mm porosity. This was immersed in DMEM. The well was then inoculated with 1873 cells. A number of replicate cultures were set up and, at different time intervals, the cells from the central well were removed simultaneously with cells in coculture on the bottom of the Petri dish. In the bottom layer, a very high level of expression was found at 2 days and later, but only a low level of expression was found in the cells above the membrane even after 6 days' incubation ( Figure 3) . We therefore concluded that direct contact between the two cell types was necessary for substantial expression of the gene.
Effects of cocultivation on methylation of the ASY promoter
Although in initial studies both wild-type 1929 and 1873 were fully methylated in the ASY promoting region, 12 after coculture for 30 or more days, methylation was largely lost and individual DNA clones showed only scanty and inconstant methylation sites (Figure 4) . Importantly, these changes occurred in an indistinguishable way in 1929 and 1873 cocultures whether or not the medium in which they had been established was supplemented with ASN ( Figure 4c and d) . The SN3 subline of 1873 was almost completely demethylated, and in a total of 30 clones each showed between one to three inconstant sites of methylation. Other sublines appeared to stabilize with a higher number of methylated sites, including a small number of completely methylated individual clones (Figure 4) . However, the sublines remained generally demethylated over at least 90 cell generations, and none showed reversion to the wild-type pattern.
We then sought to establish a time relationship between the development of demethylation and the expression of ASY ( Figure 5 ). Wild-type 1873 cells were cultivated on a macrophage layer and at 14 days were examined for ASY expression and for methylation profile. At this time substantial ASY had been induced but nonetheless, all clones remained fully methylated. The culture at 115 days showed extensive and 6 1873 cells were added. The central well (porosity: 0.4 mm) was then inserted, which rapidly filled with medium after which it was innoculated with an equal number of leukemic cells. Nine culture systems were set up, and at 48, 96, and 144 h, all suspended cells in the well and from the lower plate were separately removed for measurement of ASY expression.Cultures at each time period were in triplicate.
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Y Ding et al almost complete demethylation with a higher level of ASY expression. This pattern was followed less closely by cocultivation of 1873 with human primary culture fibroblasts. In this case, at 5 days, there was only a relatively low level of ASY induction and methylation remained complete. At 12 days, there was a moderate degree of demethylation accompanying marked ASY induction, and at 20 days, expression was higher and demethylation more extensive. Cells of the 1873 subline SN3 and four similar 1929 sublines recovered from coculture remained only scantily methylated on prolonged culture in ASN-supplemented medium, after a period of more than 200 cell generations, and ASY remained repressed on a continued basis. We have on no occasion been able to obtain ASNindependent variants on returning the cells to ASN-depleted medium. To understand the stability of ASY silencing in the various lines and sublines of leukemic cells in standard suspension culture in contrast to the strong expression in coculture, we examined the transcriptional control associated with histone modification, a process known to be associated with gene methylation.
10,11
Effects of cocultivation on modifications of ASYassociated histone
In ChIP assays, wild-type 1873 cells showed deacetylation of histone H3 at lysine 9 (H3K9) and demethylation of H3K4, and a similar pattern was seen with the ASN-dependent variant SN3 in which the ASY promoter was demethylated (Figure 6b) . However, in proliferating cells cocultured with macrophages, these modifications were reversed: H3 became acetylated and H3K4, dimethylated. 1929 showed similar changes. Raji cells, intrinsically ASN prototrophic, showed a histone pattern in standard culture similar to that of the other cocultivated and proliferating leukemic cells. Observations on the effect of the histone deacetylase inhibitor trichostatin A in increasing ASY expression on the wild-type cells, were consistent with the changes in acetylation which have been described: expression in 1873 increased to a maximum of seven-fold (600 nM at 24 h).
A difference between ASY and numerous other genes occurs with methylation of H3K9. In the case of 1873, no signal was Epigenetics of asparagine synthetase in leukemic cells Y Ding et al demonstrable by ChIP using three different immunoprecipitating antibodies to this histone form. However, controls using Raji, in which the promoter of p16 is known to be methylated and the gene repressed, 18 gave a positive signal for H3K9 methylation associated with this gene (Figure 6 ).
Discussion
The nature and propagation of the stimulus, and subsequent intracellular events which cause leukemic cells to express and demethylate ASY in the experimental system described are unknown, and not immediately comparable to other effects of cell-to-cell contact. In vivo, the principal site of proliferation of leukemic cells is in the marrow, and there is an extensive literature on its microenvironment and the role of different elements of the matrix, particularly stromal cells, on the growth characteristics of normal and leukemic hemopoietic cells. 19, 20 The extent to which stromal cells have specific characteristics is not well defined and observations made on them may be applicable to many cell types, including those we have used.
By the use of cocultures we have shown different levels in the control ASY expression in leukemic lines: repression in wildtype cells in which the promoter is methylated, and a separate underlying repression, independent of methylation. This has its counterpart in certain other genes, such as transgenes and those on the inactivated X chromosome, in which the gene is first silenced and, in a subsequent step, their promoters become methylated, leading to a stabilization of repression. 21, 22 We have strong evidence that the permanent demethylation of ASY which occurs in coculture is an epigenetic change and is not due to the proliferation of a minor population with a growth advantage, present in the original inoculum. First, while only full methylation has been observed in wild-type cells in more than 100 DNA clones examined, the development of demethylation does not appear as a clonal process, but rather to be evolutionary with a progressive and random pattern. Secondly, ASY demethylation (as well as expression) occurs in cocultures that are supplemented with ASN to optimal levels ( Figure 4d ) in a manner indistinguishable from standard cultures in ASNdepleted medium. This contrasts with the notable stability of methylation in wild-type cells grown routinely as suspension cultures in ASN-supplemented medium, in which the cells proliferate vigorously, and indeed at a higher rate than demethylated sublines. In the absence of an active process, the most likely cause for demethylation in the present experiments is by nonmethylation of the newly synthesized strand during DNA replication. 10 This is consistent with the important concept of Turker who has proposed a shifting pattern of promoter methylation in relation to gene expression. 23 Extensive methylation of the promoter of ASY, a housekeeping gene, in leukemic cells of the mouse and in humans is anomalous. There are abundant examples of hypermethylation of promoter regions of genes in association with tumors, and in many cases it confers a growth advantage by the inhibition of suppressor genes. 24 This does not apply in the present case. However, the sequence of an initially silenced and methylated gene, followed by expression and then permanent demethylation is characteristic of a number of immunologically important genes, notably INF gamma and IL-4, during lymphoid ontogenesis. 25, 26 This suggests that ASY may become aberrantly involved in such lymphoid-specific processes. ChIP of various cell lines using antibodies to substituted histone H3 (PCR amplication of associated ASY and p16 promoters). Ac: anti H3 diacetyl K9; K4: anti H3 dimethyl K4; K9: anti H3 dimethyl K9; Bl: immunoglobulin blank; I: input DNA. The four experiments in rows 1 and 2 were run simultaneously, as were the two in row 3. All cells were proliferating in RPMI 1840 36 h after addition of fresh medium.
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Transcriptionally active and inactive chromatin are distinguished by covalent modification of core histone tails. 14 The interplay between histones and protein complexes, including those linked to methylated DNA, determines the pattern which these modifications assume. 11, 13 We have shown that concomitantly with ASY expression in coculture, acetylation of H3K9 and methylation of H3K4 occurs, a characteristic pattern for a gene to be expressed. These modifications are deleted when ASY is silenced, but irrespective of promoter methylation, the expected methylation of H3K9 was not seen. Histones methylated at this site bind a complex containing HT1 which causes the chromatin of the nucleosomal unit to be converted into densely packed 'facultative' heterochromatin. 27 The lack of this change can provide an explanation for the ready reversibility of silencing and expression of ASY, as is the case with a number of other genes of hemopoetic cells. 26, 28 It can also account for the failure of remethylation of ASY in cells after coculture. 15 Our results differ from those of Bachman et al, 29 who studied p16 in colonic carcinoma cell lines where, in the specific experimental conditions they used, the primary event in repression was H3K9 methylation. Other histone changes and methylation of the p16 promoter followed significantly later. The cell lines we have used have been derived from two aggressive and relatively uncommon forms of ALL. 30 However, since a high proportion of patients respond (at least initially) to Lasparaginase, 31 it is highly probable that some abnormality of ASN metabolism exists in other forms of the disease. Indeed, in about one-third of cases of ALL (not selected by clinical or cytogenetic type), the ASY promoter is highly methylated (JD Broome, unpublished observations). L-asparaginase appears to have its greatest long-term effect in the subset of patients with TEL/AML1 fusions. We have examined one cell line (REH) with this characteristic. 12 We found it to be ASN prototrophic and to have a high level of expression of ASY, although cloning showed cells to contain individually a fully methylated and an unmethylated allele, making uncertain the status of the gene in the cell of origin of the line. In marrow and peripheral blood samples from patients with this translocation, ASY expression has been reported to be high, and in culture of leukemic marrow, the gene is expressed. 32, 33 These findings appear to contradict the view that defective ASY expression in human leukemic cells is the basis of asparaginase sensitivity, as has been convincingly shown in animal tumors. Certainly, it is possible that there are multiple different mechanisms for the action of asparaginase, both direct and indirect. The present experiments, however, show the possibility of a unitary explanation. As an extension of concepts of Dick and others 34, 35 it is suggested that in vivo the leukemic cell population forms compartments, which differ in cell environment, and this determines whether ASY is expressed or not. If the nonexpressing compartment were relatively small, it would be unrecognized by measurements of total ASY expression. Such a compartment might consist of the renewable element(s) of the population; this can be tested experimentally.
